Cytovale
Cytovale is a commercial-stage medical diagnostics company focused on early detection technologies for fast-moving and immune-mediated diseases. Their flagship product, IntelliSep, is an FDA-cleared rapid sepsis diagnostic test that helps hospitals save lives and reduce costs by enabling quicker and more accurate diagnosis and treatment.
Buy Funded Startups lists
Funding Round: Series D
Funding Amount: $100M
Date: 10-Oct-2024
Investors: Sands Capital, Canada Pension Plan Investment Board (CPP Investments), Norwest Venture Partners, Global Health Investment Corporation, Breakout Ventures
Markets: Medical Diagnostics, Healthtech, Artificial Intelligence (AI), Life Science, Machine Learning
HQ: South San Francisco, California, United States
Founded: 2013
Website: https://cytovale.com/
LinkedIn: https://www.linkedin.com/company/cytovale/
Twitter: https://x.com/cytovale
Crunchbase: https://www.crunchbase.com/organization/cytovale
Leave a Comment
Comments
No comments yet.